Spectrum Pharma reports 4Q loss

HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Tuesday reported a loss of $28.6 million in its fourth quarter.

The Henderson, Nevada-based company said it had a loss of 29 cents per share.

The biotechnology company posted revenue of $28.6 million in the period.

For the year, the company reported that its loss widened to $91.2 million, or $1.07 per share. Revenue was reported as $128.4 million.

Spectrum Pharma expects full-year revenue in the range of $90 million to $110 million.

Spectrum Pharma shares have risen 11 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $21.09, more than tripling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SPPI at https://www.zacks.com/ap/SPPI